(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 10.46% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.94%.
Atricure's revenue in 2025 is $499,946,000.On average, 4 Wall Street analysts forecast ATRC's revenue for 2025 to be $26,361,879,023, with the lowest ATRC revenue forecast at $26,341,749,950, and the highest ATRC revenue forecast at $26,372,564,827. On average, 4 Wall Street analysts forecast ATRC's revenue for 2026 to be $29,627,013,482, with the lowest ATRC revenue forecast at $29,115,088,907, and the highest ATRC revenue forecast at $29,958,521,920.
In 2027, ATRC is forecast to generate $33,650,343,026 in revenue, with the lowest revenue forecast at $33,444,082,154 and the highest revenue forecast at $33,770,123,436.